New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Olink Holding AB (publ)
OLK
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3B

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

3B

Medical - Diagnostics & Research

Next Earning date - 13 Nov 2024

26.08USD
Shape0.08 ( 0.31%)
favorite-chart

Relative Strenght

76
favorite-chart

Volume Buzz

245%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 23, 2024
1W % 1M % 3M % 1Y 4.45 %

Key Metrics

Shape
  • Market Cap

    3.24B


  • Shares Outstanding

    124.34M


  • Share in Float

    40.95M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    26.08


  • Average Volume

    545957


  • Beta

    0.517


  • Range

    14.1-26.09


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.olink.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

18.91x

P/S Ratio

7.03x

P/B Ratio

0.1

Debt/Equity

-19.7%

Net Margin

$-0.3

EPS

How OLK compares to sector?

P/E Ratio

Relative Strength

Shape

OLK

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$283M

Shape889%

2025-Revenue

$0.49

Shape477%

2025-EPS

$30M

Shape-45%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Scotiabank

initialise

Previous: Not converted

2023-01-05

Now: Sector Outperform

Canaccord Genuity

initialise

Previous: Not converted

2022-12-14

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.04
vs -0.09

Q3.22

arrow
arrow

N/A

-0.01
vs -0.05

Q4.22

arrow
arrow

+171%

0.05
vs -0.07

Q1.23

arrow
arrow

N/A

-0.11
vs -0.10

Q2.23

arrow
arrow

N/A

-0.07
vs -0.04

Q3.23

arrow
arrow

N/A

-0.01
vs -0.01

Q4.23

arrow
arrow

N/A

-0.06
vs 0.05

Q1.24

arrow
arrow

N/A

-0.13
vs -0.11

Q2.24

arrow
arrow

N/A

-0.14
vs -0.07

Q3.24

arrow
arrow

N/A

-0.04
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+56%

27.5M  vs 17.7M

Q3.22

arrow
arrow

+59%

31.8M  vs 20M

Q4.22

arrow
arrow

+33%

57.9M  vs 43.7M

Q1.23

arrow
arrow

+21%

27.5M  vs 22.7M

Q2.23

arrow
arrow

+7%

29.4M  vs 27.5M

Q3.23

arrow
arrow

+39%

44.2M  vs 31.8M

Q4.23

arrow
arrow

+20%

69.3M  vs 57.9M

Q1.24

arrow
arrow

+4%

28.6M  vs 27.5M

Q2.24

arrow
arrow

+21%

35.8M  vs 29.4M

Q3.24

arrow
arrow

+26%

55.7M  vs 44.2M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-1%

-0.01
vs -0.03

Q3.22

arrow
arrow

0%

-0.00
vs -0.01

Q4.22

arrow
arrow

+1%

0.01
vs -0.00

Q1.23

arrow
arrow

-3%

-0.03
vs 0.01

Q2.23

arrow
arrow

-2%

-0.02
vs -0.03

Q3.23

arrow
arrow

0%

-0.00
vs -0.02

Q4.23

arrow
arrow

-2%

-0.02
vs -0.00

Q1.24

arrow
arrow

-3%

-0.03
vs -0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

54

54
vs 54

NA

Q4.22

arrow
arrow

59

59
vs 54

9%

Q1.23

arrow
arrow

59

59
vs 59

NA

Q2.23

arrow
arrow

59

59
vs 59

NA

Q3.23

arrow
arrow

58

58
vs 59

-2%

Q4.23

arrow
arrow

88

88
vs 58

52%

Q1.24

arrow
arrow

98

98
vs 88

11%

Q2.24

arrow
arrow

89

89
vs 98

-9%

Earnings Growth

Latest News